Hormonal link to osteoarthritis discovered

Researchers from Chonnam National University in South Korea have identified a hormonal pathway that connects hypertension to cartilage destruction, as reported in a study published on October 1, 2026, in Science.

Traditional view of osteoarthritis challenged

Osteoarthritis has long been thought to result from mechanical wear and tear, aging, and being overweight. This new research, however, suggests that the condition may also originate in the blood, specifically affecting joints that are already damaged.

Vasopressin’s role in hypertension

Individuals with hypertension have higher levels of vasopressin, a hormone that constricts blood vessels and retains water, which raises blood pressure. This hormone needs a specific receptor, AVPR1A, to function effectively.

Cartilage and the AVPR1A receptor

Healthy cartilage contains only small amounts of the AVPR1A receptor, meaning it is largely unaffected by vasopressin. However, aging and injuries can change this, prompting cartilage cells to produce more of the receptor.

Hormone-induced cartilage damage

Once the AVPR1A receptor is present, vasopressin can bind to it, starting a chemical process that breaks down the tissue. This is described as a "priming" effect, where injury prepares the joint and hypertension provides the activating signal, making an aged or injured joint more vulnerable to the effects of high blood pressure.

Mouse study points to potential treatment

In experiments on mice, blocking the AVPR1A receptor was found to reduce cartilage damage, suggesting that targeting this receptor could be a new therapeutic approach for osteoarthritis.